SynAct Pharma AB (SYNACT) — Financial Flexibility Index
SynAct Pharma AB (SYNACT) has a Financial Flexibility Index of -0.75x as of March 2026. Free cash flow of Skr-32.95 Million (operating CF Skr-32.95 Million minus capex Skr0.00) represents -1% of total liabilities (Skr44.13 Million). Check total reinvestment intensity of SynAct Pharma AB to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SynAct Pharma AB Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for SynAct Pharma AB across 10 annual periods. For the full cash flow conversion analysis, see SYNACT cash generation efficiency.
Annual Financial Flexibility Index for SynAct Pharma AB (2016–2025)
Year-by-year free cash flow to debt coverage for SynAct Pharma AB. Explore SynAct Pharma AB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.94x | Skr-97.33 Million | Skr-97.33 Million | Skr50.23 Million | ▼ -22.4% |
| 2024 | -1.58x | Skr-89.20 Million | Skr-89.20 Million | Skr56.35 Million | ▲ +18.1% |
| 2023 | -1.93x | Skr-100.18 Million | Skr-100.18 Million | Skr51.83 Million | ▲ +73.6% |
| 2022 | -7.31x | Skr-117.56 Million | Skr-117.56 Million | Skr16.08 Million | ▼ -96.9% |
| 2021 | -3.71x | Skr-65.00 Million | Skr-65.00 Million | Skr17.50 Million | ▼ -2126230.4% |
| 2020 | 0.00x | Skr-1.00K | Skr-33.24 Million | Skr5.72 Million | ▲ +100.0% |
| 2019 | -1.52x | Skr-15.62 Million | Skr-16.12 Million | Skr10.31 Million | ▲ +76.7% |
| 2018 | -6.52x | Skr-24.21 Million | Skr-24.21 Million | Skr3.72 Million | ▲ +11.0% |
| 2017 | -7.32x | Skr-16.94 Million | Skr-17.20 Million | Skr2.31 Million | ▼ -84.9% |
| 2016 | -3.96x | Skr-13.83 Million | Skr-14.73 Million | Skr3.49 Million | — |